自然-医学杂志 NATURE MED - Nature Medicine
博文
《自然-医学 Nature Medicine 》杂志的 H-指数240
|||
临床医生应该看《自然 Nature》系列期刊论文，除了医学类论文，也应该关注最权威的国际期刊上发表的科学研究动态与进展。
这个杂志的H-指数240，在综合性医学期刊中第十名。
发文量 Publications: 8,262
被引量 Citation Count: 268,260 (自引量 Self-Citation: 2970)
H-指数 H-Index: 240
年限 Year Range: 1995-2012
学科领域 Interests: 医学 Medicine
| Journals | Publications |
| ||
|---|---|---|---|---|
| N ENGL J MED - New England Journal of Medicine | 57306 | 459 | ||
| Lancet | 233278 | 331 | ||
| JAMA-J AM MED ASSN - Jama-journal of The American Medical Association | 53183 | 306 | ||
| J EXP MED - Journal of Experimental Medicine | 21872 | 267 | ||
| J CLIN INVEST - Journal of Clinical Investigation | 27228 | 265 | ||
|
6 |
PSYCHOL BULL - Psychological Bulletin | 10461 | 261 | |
| PSYCHOL REV - Psychological Review | 6346 | 251 | ||
| PSP - Journal of Personality and Social Psychology | 14702 | 244 | ||
| Neuron | 7898 | 243 | ||
| NATURE MED - Nature Medicine | 8262 | 240 |
http://academic.research.microsoft.com/
《自然 Nature》杂志对医生真的没用吗？
2012年最重要的新药
精选
http://blog.sciencenet.cn/home.php?mod=space&uid=563591&do=blog&quickforward=1&id=647752
Straight talk with... Robert Beall,10.1038/nm0312-335,Nature Medicine,Elie Dolgin E
'Venture philanthropy' has become a buzz term in the nonprofit sector over the past decade, but the concept was completely new to disease-focused charities when the Cystic Fibrosis Foundation decided to give it a try in 1998. Frustrated by the lack of progress toward targeted therapies for cystic fibrosis—a rare disease that afflicts just 70,000 people worldwide—Robert J. Beall, president and chief executive of the Bethesda, Maryland–based organization, added a bold new component to the foundation's research-funding strategy. Beall, who joined the foundation in 1980, launched a program aimed at absorbing the early financial risk involved in drug development as a way to entice for-profit companies to get involved in cystic fibrosis research.That strategy was vindicated with the approval in January of the first small-molecule drug that directly interacts with the mutated protein responsible for cystic fibrosis. The drug, formerly known as VX-770 and now branded as Kalydeco (ivacaftor), has been a long time in the making. Yet all along the way there was Beall and his foundation, which has committed $315 million to for-profit companies for cystic fibrosis research over the years. Elie Dolgin spoke with Beall to learn more about his organization's pioneering approach to philanthropy.
DOI: 10.1038/nm0312-335
中国科学家Nature medicine发布肝癌研究新成果
来自香港大学、新加坡国立大学、中山大学癌症中心等处的研究人员发表了题为“Recoding RNA editing of AZIN1 predispose to hepatocellular carcinoma”的研究论文，证实ADAR 介导的AZIN1基因 A至I RNA编辑是诱发肝癌的一个潜在因素，研究成果发布在1月6日的《自然医学》（Nature medicine）杂志上。
https://wap.sciencenet.cn/blog-280034-649017.html
上一篇：2012年国内十大经济新闻和国际十大经济新闻
下一篇：黄灯是中国人发明的
